Boston Scientific
757 hedge funds and large institutions have $55.4B invested in Boston Scientific in 2019 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 281 increasing their positions, 261 reducing their positions, and 101 closing their positions.
79% more call options, than puts
Call options by funds: $229M | Put options by funds: $128M
20% more funds holding in top 10
Funds holding in top 10: 15 → 18 (+3)
13% more capital invested
Capital invested by funds: $49.1B → $55.4B (+$6.35B)
8% more repeat investments, than reductions
Existing positions increased: 281 | Existing positions reduced: 261
0.86% more ownership
Funds ownership: 91.94% → 92.8% (+0.86%)
4% less funds holding
Funds holding: 789 → 757 (-32)
20% less first-time investments, than exits
New positions opened: 81 | Existing positions closed: 101
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nuveen
Charlotte,
North Carolina
|
+$333M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$230M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$222M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$197M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$196M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$457M |
| 2 |
BlackRock
New York
|
-$185M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$120M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$118M |
| 5 |
Two Sigma Investments
New York
|
-$101M |
BSX Hedge Fund Activity: Q2 2019 in Review
757 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2019, worth a combined $55.4B — up 13% from $49.1B a quarter earlier.
Sellers outnumbered buyers: 101 funds closed out of BSX and 81 opened new positions — a net loss of 20 holders — while 261 trimmed existing stakes and 281 added.
The largest buyer was Nuveen, adding an estimated $333M. The largest seller was Fidelity Investments, cutting an estimated $457M.
- 757 institutional investors held Boston Scientific (BSX) as of Q2 2019, down from 789 in Q1 2019.
- Funds reported $55.4B of Boston Scientific stock for Q2 2019, up 13% quarter-over-quarter.
- 81 funds opened new Boston Scientific positions in Q2 2019 and 101 closed out, a net change of -20 holders.
- The largest Boston Scientific buyer in Q2 2019 was Nuveen, an estimated $333M added.
- The largest Boston Scientific seller in Q2 2019 was Fidelity Investments, an estimated $457M sold.
Based on aggregated 13F filings for Q2 2019.